These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9607238)

  • 1. [Ecstasy: a forgotten drug].
    Avila de Tomás JF; Salas Dueñas R; García Martín P
    Aten Primaria; 1998 Feb; 21(3):180. PubMed ID: 9607238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ecstasy: from recreational drug to toxic substance].
    Franck N; Bertrand J
    Rev Med Liege; 1997 Nov; 52(11):715-22. PubMed ID: 9480498
    [No Abstract]   [Full Text] [Related]  

  • 3. Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    Goss J
    JEMS; 2001 Jun; 26(6):84-7, 90-3; quiz 94. PubMed ID: 11409205
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary retention with misuse of "ecstasy".
    Bryden AA; Rothwell PJ; O'Reilly PH
    BMJ; 1995 Feb; 310(6978):504. PubMed ID: 7888894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis from ecstasy].
    Giner Durán R; Flors H; Millán M; Manzanera R
    Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ecstasy--adolescents and drugs].
    Holler A
    Kinderkrankenschwester; 1998 Feb; 17(2):80-3. PubMed ID: 9536687
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new drugs: ecstasy, GHB. Update for practitioners].
    Feldman N; Croquette-Krokar M
    Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
    [No Abstract]   [Full Text] [Related]  

  • 8. Party-drugs: sociocultural and individual background and risks.
    Gerhard H
    Int J Clin Pharmacol Ther; 2001 Aug; 39(8):362-6. PubMed ID: 11515712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxicity of ecstasy].
    Mas M; Farré M; Roset PN; Camí J
    Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ecstasy].
    Ege PP
    Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ecstasy: idiosyncrasy, overdosage or collateral effects].
    Avila de Tomás JF
    Med Clin (Barc); 1998 Oct; 111(13):517-8. PubMed ID: 9859072
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS
    Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
    [No Abstract]   [Full Text] [Related]  

  • 13. Ecstasy induced acute bilateral angle closure and transient myopia.
    Kumar RS; Grigg J; Farinelli AC
    Br J Ophthalmol; 2007 May; 91(5):693-5. PubMed ID: 17446512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Tretter F
    Nervenarzt; 1997 Nov; 68(11):922-3. PubMed ID: 9732739
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma amino acids in ecstasy users.
    Stuerenburg HJ; Petersen K; Buhmann C; Rosenkranz M; Baeumer T; Thomasius R
    Neuro Endocrinol Lett; 2003 Oct; 24(5):348-9. PubMed ID: 14647011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological problems with ecstasy and the SCL-90.
    Cole JC; Sumnall HR; Wagstaff GF
    Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ecstasy, a new designer drug in the techno-scene].
    Kuhlmann T
    Psychiatr Prax; 1996 Nov; 23(6):266-9. PubMed ID: 9036394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.